Traditional Chinese medicine preparation for treating liver disease and preparation method thereof

Abstract

The invention provides a traditional Chinese medicine preparation for treating a liver disease. The traditional Chinese medicine preparation is prepared from, by weight, 20-40 parts of artemisia japonica, 10-18 parts of rhizoma smilacis glabrae, 8-14 parts of radix bupleuri, 5-10 parts of aburs cantoniensis, 10-15 parts of musk, 12-16 parts of red radix rubiae, 20-30 parts of cordyceps sinensis, 8-12 parts of prepared fleece flower root, 6-10 parts of oriental grape root, 4-9 parts of spreading hedyotis herb, 10-16 parts of prunella vulgaris, 7-13 parts of licorice root, 3-8 parts of astragali radix, 10-18 parts of radix angelica sinensis, 5-10 parts of curcuma zedoary, 15-25 parts of salvia miltrorrhiza and 8-16 parts of chicken's gizzard-membrane. The traditional Chinese medicine preparation for treating the liver disease is prepared from 17 traditional Chinese medicine materials, can be used for treating various types of hepatitis, liver depression and blood stasis type liver, spleen and pancreas diseases, and especially has the obvious treating effect on patients with liver cirrhosis and cirrhotic ascites. Compared with western medicines, the traditional Chinese medicine preparation is prepared from the pure traditional Chinese medicine materials and is free of toxic and side effects through long-term taking.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine preparation for treating liver diseases and a preparation method thereof. Background technique [0002] With the increasing pace of people's life, increased pressure, irregular work and rest, and excessive drinking, liver diseases are becoming more and more common, including various types of hepatitis, liver cirrhosis, liver ascites, liver fibrosis, fatty liver, alcohol Diseases such as liver and liver cancer are one of the main diseases that threaten human health in today's society. Due to the complex etiology of its disease, if it is not treated in time or the treatment effect is not good, the condition will worsen. At present, the medical treatment of the above-mentioned liver diseases, especially the treatment of hepatitis B, etc., mainly adopts antiviral therapy. Patients who can receive formal antiviral treatment are still relati...

AI Technical Summary

Problems solved by technology

For example, antiviral drugs such as lamina, entecavir, ribavirin, and interferon are used for treatment, and then vitamin K1 injection, reduced glutathione, 5% glucose injection, vitamin C, potassium chloride, etc. are added to protect the liver, or taken orally Silybin Capsules, Anethrizione, etc. are used to eliminate inflammation in the liver, promote gallbladder and reduce jaundice, but the effect of these treatments is not ideal, the cure is slow, and the cure rate is low

[0003] Chinese patent CN 103099979B discloses a traditional Chinese medicine for treating hepatitis, liver cirrhosis and hepatic ascites, which was invented to solve the reasons such as the poor therapeutic effect of existing medicines

But this invention is slow to take effect, and the cure basically depends on the improvement of self-immunity

The patent application of CN1268362A discloses a kind of medicine for the treatment of chronic hepatitis, liver fibrosis and early liver cirrhosis, which is composed of astragalus, salvia miltiorrhiza, angelica, safflower, Chuan Shao, Cyperus cyperi, red peony root, Bupleurum radix, tangerine peel, and spatholobus Composed of a variety of active ingredients, but the drug has a low cure rate and high long-term rebound

[0004] However, the pharmaceutical compositions in the prior art are often unsatisfactory, for example, they often show shortcomings such as insufficient curative effect, single effect, and large dosage.